Gas

McDermott and Chiyoda announce first liquid from Cameron LNG Train 3

While production is in the initial phases, this significant project accomplishment is a precursor to substantial completion of Train 3 and comes just weeks after announcing introduction of feed gas to Train 3 on April 22.

  • By ICN Group | May 19, 2020

McDermott International, Inc. and its joint venture partner, Chiyoda International Corporation have announced that Train 3 of the Cameron LNG project in Hackberry, La., has begun producing liquefied natural gas (LNG). While production is in the initial phases, this significant project accomplishment is a precursor to substantial completion of Train 3 and comes just weeks after announcing introduction of feed gas to Train 3 on April 22.
 
"I applaud the hard work and commitment of the entire joint venture project team whose focus on safety and delivery during this dynamic time brought Train 3 to the state of producing liquefied natural gas," said Mark Coscio, McDermott's Senior Vice President for North, Central and South America. "The teamwork and diligence they have placed on safety and health as we navigate through the current COVID-19 pandemic has enabled us to continue our operations and deliver the project."
 
McDermott and Chiyoda have provided the engineering, procurement and construction for the Cameron LNG project since the project's initial award in 2014. The project includes three liquefaction trains with a projected export of 12 million tonnes per annum of LNG, or approximately 1.7 billion cubic feet per day.
 
Cameron LNG is jointly owned by affiliates of Sempra LNG LLC, Total, Mitsui & Co., Ltd. and Japan LNG Investment, LLC, a company jointly owned by Mitsubishi Corporation and Nippon Yusen Kabushiki Kaisha (NYK).

'Participate in ICN Compendium on Chemical Industry Outlook 2021' Click here to know more

Startup

Chemical

Petrochemical

Digitization

India should focus on pharma intermediates self-sufficiency
Dr. K. Nagaiah CSIR-IICT, Hyderabad,Chief Scientist & Head - Centre for Natural Product and Traditional Knowledge
India should focus on pharma intermediates self-sufficiency